文献速递头痛与眩晕认知障碍与痴呆

58例视觉雪花患者的治疗效果与共病疾病

Treatment effects and comorbid diseases in 58 patients with visual snow.
PubMed 文献 · Neurology · 2019-06-18

本研究回顾性分析了2007至2018年神经内科门诊58例视觉雪花患者的用药及共病情况。拉莫三嗪最常处方(26/58),仅5/26(19.2%)部分缓解,无完全缓解,13/26(50.0%)出现不良事件;偏头痛、抑郁、焦虑和耳鸣常见。

要点

  • 拉莫三嗪治疗视觉雪花仅少数患者部分缓解,半数出现不良事件。
  • 视觉雪花患者中偏头痛、抑郁、焦虑和耳鸣共病率高。
  • 其他药物如丙戊酸、托吡酯等未见改善,托吡酯因不良事件停药。

核心结论

  • 在处方药物中,仅拉莫三嗪对少数视觉雪花患者有部分改善作用。
  • 偏头痛、抑郁、焦虑和耳鸣是常见的共病疾病。

研究设计与样本

  • 回顾性病历审查,纳入2007至2018年神经内科门诊诊断为视觉雪花的58例患者。

主要发现

  • 偏头痛共病率为51.7%,终生抑郁为41.4%,终生焦虑为44.8%。
  • 拉莫三嗪处方26/58例,部分缓解5/26(19.2%),无完全缓解,不良事件13/26(50.0%)。
  • 其他药物(丙戊酸7例、托吡酯4例、乙酰唑胺2例、氟桂利嗪1例)除托吡酯1例改善但因不良事件停药外,均无改善。

关键数值与推荐

  • 拉莫三嗪部分缓解率19.2%(5/26),不良事件发生率50.0%(13/26)。
  • 偏头痛51.7%,终生抑郁41.4%,终生焦虑44.8%。

临床怎么用

  • 对视觉雪花患者应评估偏头痛、抑郁、焦虑和耳鸣等共病。
  • 拉莫三嗪可尝试但需监测不良事件,疗效有限。

局限性

  • 回顾性研究,证据等级为Class IV。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate pharmacologic treatment options for visual snow and to report prevalence of comorbid diseases. METHODS: Medical charts of patients with a diagnosis of visual snow at the neurology outpatient clinic were reviewed on prescribed medication, and comorbid migraine, tinnitus, and psychiatric conditions including depression and anxiety. RESULTS: From 2007 to 2018, 58 patients were diagnosed with visual snow. Comorbid migraine was present in 51.7% of patients, lifetime depression in 41.4%, and lifetime anxiety in 44.8%. Lamotrigine was prescribed most frequently (26/58) and resulted in partial remission of symptoms in 5/26 (19.2%). No patients reported complete remission. Adverse events occurred in 13/26 (50.0%) patients. None of the other prescribed drugs (valproate [n = 7], topiramate [n = 4], acetazolamide [n = 2], flunarizine [n = 1]) led to improvement except for topiramate in one patient, who discontinued, however, because of adverse events. CONCLUSIONS: Of medication prescribed (lamotrigine, valproate, acetazolamide, flunarizine), only lamotrigine afforded some improvement in a small minority of patients. Migraine, depression, anxiety, and tinnitus were common comorbid diseases. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that for some patients with visual snow, lamotrigine resulted in partial remission of symptoms.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. van Dongen RM, Waaijer LC, Onderwater GLJ, et al. Treatment effects and comorbid diseases in 58 patients with visual snow. Neurology. 2019. PMID: 31213497. doi:10.1212/WNL.0000000000007825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。